Literature DB >> 6490964

Propranolol in the treatment of assaultive patients with organic brain disease.

R M Greendyke, D B Schuster, J A Wooton.   

Abstract

Propranolol in doses up to 520 mg/day was administered to eight patients with organic brain disease characterized by violent and assaultive behavior refractory to conventional treatment. Improvement was demonstrated in the seven patients able to tolerate adequate drug dosages. Hypotension, bradycardia, and interactions with other medications constituted complications.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6490964

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


  6 in total

Review 1.  Therapeutic uses of beta-adrenoceptor blocking drugs in the central nervous system in man.

Authors:  P Turner
Journal:  Postgrad Med J       Date:  1989-01       Impact factor: 2.401

2.  Successful management of difficult-to-treat aggression with low-dose propranolol in a patient with intellectual disability: a case report.

Authors:  Ravi Philip Rajkumar
Journal:  Prim Care Companion CNS Disord       Date:  2012-10-04

3.  Open trial effects of beta-blockers on speech and social behaviors in 8 autistic adults.

Authors:  J J Ratey; J Bemporad; P Sorgi; P Bick; S Polakoff; G O'Driscoll; E Mikkelsen
Journal:  J Autism Dev Disord       Date:  1987-09

Review 4.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

5.  Clinical and demographic characteristics of 15 patients with repetitively assaultive behavior.

Authors:  J W Barber; P Hundley; E Kellogg; J L Glick; L Godleski; R Kerler; W V Vieweg
Journal:  Psychiatr Q       Date:  1988

6.  Beta adrenergic blockade reduces utilitarian judgement.

Authors:  Sylvia Terbeck; Terbeck Sylvia; Guy Kahane; Kahane Guy; Sarah McTavish; McTavish Sarah; Julian Savulescu; Savulescu Julian; Neil Levy; Levy Neil; Miles Hewstone; Hewstone Miles; Philip J Cowen
Journal:  Biol Psychol       Date:  2012-10-23       Impact factor: 3.251
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.